These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 3954334)
1. Uptake enhancement of platinum in the dog kidney by microencapsulation of cisplatin and local injection. Hecquet B; Depadt G; Fournier C; Meynadier J Anticancer Res; 1986; 6(1):65-9. PubMed ID: 3954334 [TBL] [Abstract][Full Text] [Related]
2. [Serum concentration and distribution in the liver, lung, heart and kidney of platinum after hepatic arterial injection in the form of cis-diammine dichloroplatinum microcapsule in rabbits]. Wang Y Zhonghua Wai Ke Za Zhi; 1990 Nov; 28(11):686-8, 704. PubMed ID: 2086077 [TBL] [Abstract][Full Text] [Related]
3. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs. Litterst CL; Gram TE; Dedrick RL; Leroy AF; Guarino AM Cancer Res; 1976 Jul; 36(7 PT 1):2340-4. PubMed ID: 1277140 [TBL] [Abstract][Full Text] [Related]
4. [Studies on adequate intervals of cisplatin administration to ameliorate cisplatin-induced nephrotoxicity]. Sakatoku H; Kawai K; Kamiya H; Sakurai M Gan To Kagaku Ryoho; 1986 Feb; 13(2):239-46. PubMed ID: 3947105 [TBL] [Abstract][Full Text] [Related]
6. [Tissue platinum distribution and the effect following intra-arterial injection of cisplatin to metastatic liver cancer--a case report]. Nemoto H; Takeuchi S; Yoshizawa Y; Uemichi O; Sasaya S; Yamaguchi M; Makuuchi M; Midorikawa T; Sanada Y; Kumada K; Takizawa K Gan To Kagaku Ryoho; 2001 Aug; 28(8):1149-53. PubMed ID: 11525035 [TBL] [Abstract][Full Text] [Related]
7. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
8. Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals. Litterst CL; LeRoy AF; Guarino AM Cancer Treat Rep; 1979; 63(9-10):1485-92. PubMed ID: 498147 [TBL] [Abstract][Full Text] [Related]
9. Increase in serum uric acid level associated with cisplatin therapy. Correlation with liver but not kidney platinum concentrations. Nanji AA; Mikhael NZ; Stewart DJ Arch Intern Med; 1985 Nov; 145(11):2013-4. PubMed ID: 4062451 [TBL] [Abstract][Full Text] [Related]
10. Effects of intralesional injection of cisplatin on squamous cell carcinoma and normal tissue of mice. Landrito JE; Yoshiga K; Sakurai K; Takada K Anticancer Res; 1994; 14(1A):113-8. PubMed ID: 8166436 [TBL] [Abstract][Full Text] [Related]
11. Effect of time of cisplatin administration on its toxicity and pharmacokinetics in dogs. Hardie EM; Page RL; Williams PL; Fischer WD Am J Vet Res; 1991 Nov; 52(11):1821-5. PubMed ID: 1686160 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study of the action of antineoplastic platinum compounds with varying nephrotoxic effects]. Bakhteeva VT; Fok EM; Lavrova EA Vopr Med Khim; 1996; 42(4):301-6. PubMed ID: 9254514 [TBL] [Abstract][Full Text] [Related]
13. Whole-body autoradiographic study of the distribution of 195mPt in healthy and tumor-bearing mice treated with labeled cisplatin. Bénard P; Desplanches G; Macquet JP; Simon J Cancer Treat Rep; 1983 May; 67(5):457-66. PubMed ID: 6406060 [TBL] [Abstract][Full Text] [Related]
14. Failure of cis-platinum to alter metal concentrations in the liver and kidney of the rat. Kinsler S; Bell JU Biochem Int; 1985 Jun; 10(6):847-53. PubMed ID: 4041185 [TBL] [Abstract][Full Text] [Related]
15. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats. Esposito M; Vannozzi M; Viale M; Pellecchia C; Civalleri D; Gogioso L Anticancer Res; 1995; 15(6B):2541-7. PubMed ID: 8669820 [TBL] [Abstract][Full Text] [Related]
16. Covalent binding of platinum to renal protein from sensitive and resistant guinea pigs treated with cisplatin: possible role in nephrotoxicity. Litterst CL; Schweitzer VG Res Commun Chem Pathol Pharmacol; 1988 Jul; 61(1):35-48. PubMed ID: 3175342 [TBL] [Abstract][Full Text] [Related]
17. Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II). DeSimone PA; Yancey RS; Coupal JJ; Butts JD; Hoeschel JD Cancer Treat Rep; 1979 Jun; 63(6):951-60. PubMed ID: 466654 [TBL] [Abstract][Full Text] [Related]
18. Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role? Viale M; Vannozzi MO; Pastrone I; Mariggiò MA; Zicca A; Cadoni A; Cafaggi S; Tolino G; Lunardi G; Civalleri D; Lindup WE; Esposito M J Pharmacol Exp Ther; 2000 Jun; 293(3):829-36. PubMed ID: 10869382 [TBL] [Abstract][Full Text] [Related]
19. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate. Ognio E; Chiavarina B; Caviglioli G; Lapide M; Viale M Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682 [TBL] [Abstract][Full Text] [Related]
20. Long-term consequences of cis-platinum-induced renal injury: a structural and functional study. Dobyan DC Anat Rec; 1985 Jul; 212(3):239-45. PubMed ID: 4061878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]